Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Blood Pressure Linked to Risk Faced By Diabetics (Australia)

This article was originally published in PharmAsia News

Executive Summary

Researchers at the George Institute of International Health at the University of Sydney have discovered that reducing blood pressure can lower the risk of dying from diabetes. For the study, 11,000 patients with type 2 diabetes were divided into two groups. Half were given Coversyl Plus, a drug known to lower blood-pressure. The other half were given a placebo. Results published in The Lancet showed a 14 percent decrease in the overall risk of death for patients who were given Coversyl. Their risk of dying from cardiovascular disease was also reduced 18 percent. (Click here for more - May Require Free Registration

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066497

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel